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DISSECTION OF IR GENE CONTROL WITIt LYSOZYME PEPTIDES the induction of suppressor T cells in H-2 b mice.
In this study, we demonstrate that the N-terminal, C-terminal peptide (N-C), obtained from HEL by mild acid hydrolysis (a.a. 1-17:cys 6-cys 127:120-129) mimics the intact HEL molecule in the induction of suppressor cells in B10 and can induce helper cells in B10.A mice. The mixed disulfide peptide (LII) derived by cyanogen bromide (CNBr) treatment of HEL followed by disulfide exchange (a.a. induces helper cells in both strains. Therefore, the genetic nonresponsiveness of the B10 strain to HEL seems to be a consequence of the activation of suppressor T cells by a restricted portion of this antigen. One manifestation of MHC gene activity appears to be the intramolecular selection of different antigenic determinants leading to activation of functionally different T-cell subpopulations.
Materials and Methods
Mice. Female B10 and B 10.A were obtained from The Jackson Laboratory, Bar Harbor, Maine, and maintained in our animal facilities. All mice were between 10 and 15 wk of age when immunized.
Lysozymes. HEL was purchased from Societfi Prodotti Antibiotici, Milan, Italy. REL was isolated from egg-white by adsorption on carboxymethyl-Sephadex (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) and elution with a linear-concentration gradient of 0.05-0.8 M ammonium carbonate at pH 9.0. It was further purified by chromatography on the weakcation-exchange resin, Bio-Rex 70 (Bio-Rad Laboratories, Richmond, Calif.) with 0.2 M sodium phosphate buffer at-pH 7.18 (10) . Purity for both lysozymes was established by column chromatography and slab gel electrophoretic analysis.
Preparation and Characterization of the N-C Peptide from HEL (a.a. 1-17.'cys 6-cys 127:120-129).
The N-C peptide was prepared by mild-acid cleavage, a procedure that results in the destruction of peptide bonds at aspartic acid and asparagine residues (11) . 1 g of lysozyme was dissolved in 0.03 N HCI and extensively dialyzed using a Spectrapor No. 1 membrane (Spectrum Medical Industries, Inc., Los Angeles, Calif.) against the same solution. The solution was then transferred to a two-necked round-bottom flask, placed in a heating mantle and refluxed for 36 h while passing a stream of nitrogen through the solution. The digest was then concentrated by flash evaporation and loaded on a G-25 Sephadex column (Pharmacia Fine Chemicals, Inc.) (3.5 X 90 cm) in 5% acetic acid. Because HEL has only one histidine, at amino acid residue 15, the purification of the peptide was followed by using the Pauli reagent to detect the presence of histidine. The first major polypeptide peak eluted from the G-25 Sephadex column contained the only histidine detected. This material was concentrated and passed over a Bio-Gel P6 column (Bio-Rad Laboratories) (3.5 × 90 cm) in 5% acetic acid. The largest molecular-weight material from this column was lyophilized and further purified by binding to a CM-Sephadex C-25 column (Sigma Chemical Co., St. Louis, Mo.) (1 × 20 era) and elution with a linear (salt) gradient from 0.01 to 0.2 M ammonium acetate in 8 M urea, pH 9.0. After desalting, the material was concentrated by lyophilization. This peptide fraction had no detectable enzymatic activity at a concentration of 6 mg/ml. The threshold for this assay is <10/~g/ml HEL.
The peptide exhibited only one spot on high-voltage electrophoresis at pH 1.9. This spot contained histidine and tryptophan and no detectable tyrosine. Reduction and carboxymethylation of this peptide revealed two ninhydrin-positive spots on high-voltage electrophoresis. One of these spots contained histidine and no detectable tryptophan, corresponding to the Nterminal portion, the other tryptophan and no detectable histidine, corresponding to the Cterminal portion. Amino acid analyses were performed with a Beckman 120B amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.). Samples were hydrolyzed in sealed and evacuated Beckman tubes (Beckman Instruments, Inc.) in 6 N HCI at 110°C for 22 h. Table  I contains the amino acid composition of the peptide. These results indicate that this peptide fraction consists of a.a. residues 1-17:cys 6-cys 127:120-129 (Fig. 1 ).
Preparation and Characterization of the Lu
Peptide from HEL (a.a. . The Ln peptide was prepared by CNBr cleavage of native HEL as previously described (12), followed by disulfide exchange according to the method of Smithies (13) . Briefly, 1 g of HEL was dissolved in 100 ml of 70% formic acid and 720 mg of CNBr was added. After 24 h, the digestion was stopped by adding 10 volumes of distilled water and the preparation was lyophilized. 200 mg of CNBrdigested HEL was dissolved in 10 ml of borate buffer (0.1 M borate, 0.04 M EDTA in 8 M urea, pH 8.4). This solution was then added to 10 ml of the same buffer containing 0.2 M 2-hydroxyethyl disulfide (Aldrich Chemical Co., Inc., Milwaukee, Wis.) and 0.008 M 2-mercaptoethanol. The mixture was rocked at 37°C for 4 h and then loaded onto a G-25 Sephadex column (3.5 × 90 cm) equilibrated with 5% acetic acid. The first protein peak eluted was concentrated and passed over a G-75 Sephadex column (1 X 100 cm) equilibrated with 5% acetic acid. The major peak from this column was lyophilized and used without further purification. This peptide demonstrated a single band of apparent mol wt close to 10,000 on 10-20% polyacrylamide gel containing 0.1% SDS. No enzymatic activity was detected at 6 mg/ ml, indicating that the fraction was at least 99.8% free of intact lysozyme. The amino acid analysis of the LII peptide is shown in Table I and its sequence in Fig. 1 . 
Assay of In Vivo
Response. Suspensions were gently teased from PT-LN and sequentially passed through coarse and fine mesh screens into cold Hepes-buffered Eagle's Minimum Essential Medium (Grand Island Biological Co.) containing 0.25% gelatin (HEG). The cell suspensions were washed two times in HE(}, resuspended in cold medium and assayed for hemolytic plaque formation using the Cunningham and Szenberg technique (14) . As indicator cells, HEL coupled to guinea pig erythrocytes (Colorado Serum Co., Denver, Colo.) were used at a final concentration of 1%. HEL-erythrocyte (RBC) coupling procedures have been previously described (9) . Goat anti-mouse Ig-developing serum was used at a final dilution of 1:400 to detect IgG plaque-forming cells (PFC). Fresh guinea pig serum, adsorbed on RBC, )~0
I was used as a source of complement at a final dilution of 1:64. The results are presented as the geometric mean of PFC/l0 s nucleated PT-LN cells. An SE coefficient was calculated from the logarithmically transformed PFC, and denotes a factor which muhiplies and divides the mean to give the upper and lower limit of the SE. In Vitro Culture. In vitro experiments were performed using a miniaturized two-chamber diffusion culture system recently developed in our laboratory (15) . Culture medium was RPMI 1640 (Grand Island Biological Co.) supplemented with 10% fetal calf serum (Flow Laboratories, Inc., Rockville, Md.), 2 mM L-glutamine (Grand Island Biological Co.), 5 × 10 -5 M 2-mercaptoethanol and 10 #g/ml gentamicin (Shering Corp., Bloomfield, N. J.). Briefly, 2 × l06 spleen cells were cultured together with 2 × 106 HEL-sheep RBC (SRBC) (Grand Island Biological Co.) or HEL-human RBC (HuRBC) (from a single donor) in 0. l ml in the inner chamber, separated by a dialysis membrane from the reservoir in which 1 ml of medium was placed. On day 4 ofcuhure, triplicate cultures were harvested and tested for direct PFC against HEL-burro (donkey) RBC (BRBC), (BRBC, Colorado Serum Co.), or SRBC using the Cunningham and Szenberg technique (14) . Results are expressed as PFC/culture. SE represents the SE of the arithmetic mean PFC from triplicate cultures.
Treatment of T Cells with Antisera. Anti-T serum was rabbit anti-mouse thymocyte serum (Microbiological Associates, Walkersville, Md.) adsorbed on XS63 (a Balb/c, non-Ig-producing plasmacytoma) according to Kappler and Marrack (16) . Anti-T serum additionally adsorbed twice on B10 thymocytes (108 thymocytes/ml serum for 30 min at 4°C) was used as control. Anti-I-J b serum was prepared in our laboratory by multiple intraperitoneal injections of B 10.A (3R) spleen cells into BI0.A (5R) recipients. As a specificity control, anti I-J b serum was adsorbed four times on B10 (I-J b) or B10.A (I-J k) spleen cells (10% vol:vol) for 30 rain at 4°C. All antisera were incubated at a 1:10 final dilution with spleen cells (2 × 107/ml) for 30 min at 4°C. The cells were then washed once, resuspended in rabbit complement (Cedarlane Laboratories, London, Ontario, Canada) at a final dilution of 1:8, incubated for 30 min at 37°C, and then washed three times.
Results

N-C Priming followed by HEL Challenge In Vivo Induces Antibody Formation in BIO.A but Not in BIO Mice. Previous experiments from our laboratory demonstrated that after
HEL-CFA priming, B10.A mice respond to a soluble-HEL challenge, whereas B10 mice do not (6) . To test the effect of N-C priming, six B 10 or B 10.A mice/group were primed i.p. with a saline-CFA emulsion or with 100/.tg of HEL in CFA or 20/zg of N-C (molar equivalent to 100 #g HEL) in CFA. After 28 d, all mice were challenged with 100/xg of soluble HEL i.p. and the anti-HEL-IgG PFC response assayed 6 d later in the PT-LN. This lymphatic organ was chosen on the basis of previous work that demonstrated that, after this immunization protocol, the highest concentration of PFC is found in the PT-LN (17) . Results shown in Table II demonstrate that in both experimental groups, the response of B 10 mice was < 1 PFC/106 PT-LN cells. In B10.A mice, no response was observed after saline-CFA priming and soluble-HEL challenge, but comparable anti-HEL PFC responses were obtained after priming with either HEL-CFA or N-C-CFA.
The N-C Portion of HEL Mimics the Intact Molecule in the Induction of Suppressor Cells in BIO and Helper Cells in BIO.
A Mice. Although B 10 mice do not respond to HEL when immunized with soluble antigen or antigen in CFA, a primary anti-HEL response can be obtained, both in vivo and in vitro, if HEL is coupled to an immunogenic carrier, such as RBC (6, 9) . HEL-CFA i.p. priming in B10 mice was found to induce suppression of the anti-HEL response to HEL-RBC (9) . Results in Fig. 2 demonstrate that in vitro cultures of spleen cells from CFA-primed mice, with HEL-RBC as antigen, give a primary anti-HEL PFC response both in B10 and B10.A mice, although in the latter strain, the response is of lower magnitude. Spleen cells from B10 mice primed 4 wk before culture with 100 #g HEL-CFA give a small anti-HEL PFC response: only 15% of the primary response. Spleen cells from B10 mice primed with 20 #g of N-C-CFA give <20% of the anti-HEL PFC response attained by spleen cells from CFA-primed mice. However, when 10% of spleen cells from HEL-or N-C- Mice were primed with saline-CFA, or HEL-CFA (100 #g/mouse) or LIx-CFA (70 #g/mouse), 4 wk before culture. 2 X l0 n spleen cells and 2 X 10 ~ HEL-SRBC were cultured in triplicate miniaturized diffusion culture chambers and separately assayed, on day 4 of culture, for direct anti-ttEL and anti-SRBC PFC. PFC data are presented as arithmetic means and SE from triplicate cultures.
cultures from HEL-CFA-primed B 10 mice give a lower response, while cultures from B10.A mice produce an augmented PFC response, as compared to the respective primary responses. After Ln-CFA priming, however, both strains exhibit a significant increase in the PFC response (P <0.05). HEL-specific suppression in B10 is demonstrated by mixing 10% of spleen ceils from HEL-CFA-primed mice with 90% of cells from CFA-primed mice. In the B 10.A strain, HEL-specific helper activity is demonstrated by mixing 10% of spleen cells from HEL-CFA-primed mice with 90% of spleen cells from CFA-primed mice. A substantial amount of helper activity is obtained in both strains by coculturing 10% of spleen cells from Lii-primed mice with 90% of spleen cells from CFA-primed mice. Specificity of the HEL-induced suppression or help is illustrated by the anti-SRBC response, which is in any case very similar in the different experimental groups in each strain. Consistently, the primary anti-HEL and anti-SRBC PFC responses are lower in B10.A, as compared to the congenic B10 strain. Results in Fig. 3 demonstrate that helper activity induced by LII in B10 mice is suppressed by HEL-induced suppressor T cells. B10 mice were primed with CFA, HEL-CFA (100 #g/mouse) or LII-CFA (70 #g/mouse), and 4 wk later, their spleen cells cultured with HEL-HuRBC as antigen in vitro. Direct anti-HEL PFC assayed on day 4 demonstrate that, as expected, a lower response is obtained in spleen-cell cultures from HEL-CFA-primed mice and an augmented response in cultures from Ln-CFA-primed mice. Coculture of 5% spleen cells from HEL-CFA-primed mice with 95% spleen cells from CFA-primed mice results as expected, in strong suppression of the primary anti-HEL in vitro response. On the other hand, 5% of spleen cells from Ln-primed mice, when added to 95% spleen cells from CFA-primed mice, are able to generate the same amount of helper activity present in cultures containing 100% spleen cells from Ln-primed mice. However, the activity of the Lii-induced helper cells is almost completely suppressed by the addition of 5% spleen cells from HEL-CFA-primed mice. In B10 mice, HEL~specific suppressor T cells do not recognize the closely related, immunogenic REL, indicating that a limited region on the nonimmunogenic HEL, absent on REL, could account for the induction of suppression (9) . The presence of tyrosine at amino acid residue 3, as in REL, Japanese quail egg-white lysozyme (JEL), or turkey egg-white lysozyme (TEL), seems to correlate with immunogenicity in B10 mice. The nonimmunogenic lysozymes (e.g., HEL) have phenylalanine at this position (7, 8) . The extra glycine residue, recently detected at the amino terminus of the REL molecule (18) is probably irrelevant to the composition of the critical determinant because REL vis-a-vis JEL and TEL, which lack the extra glycine, show a similar responsiveness pattern, as judged by in vivo antibody response (6) , and in vitro T-cell proliferation (7) . Thus, the induction by the N-C fragment of HEL-specific suppressor T cells in B10 mice, and of helper cells in BI0.A mice, strongly suggests that this region is presented, under H-2-1inked Ir gene control, primarily to either suppressor T cells or helper cells. Although it seems likely that no suppressor T cells can be raised in the BI0.A strain to N-C, it is possible that this peptide of mol wt 3,000 contains both helper and suppressor determinants and that hidden suppressors (19, 20) could be revealed even in the responder strain. One approach to solving this question would be to dissociate a helper-from a suppressor-inducing portion of the N-C peptide, although it is possible that suppression and help are induced by the same epitope present in the N-C region. In any event, the use of N-C and LII peptides has allowed analysis of almost the entire HEL molecule. The five amino acid overlap between the N-C and the LI~ peptide does not seem to be relevant because different cell populations are induced, in B10 mice, by these two fragments. Fine analysis of the crucial determinant site included within the N-C fragment is currently in progress by using the isolated N-terminal and C-terminal peptides obtained from reduction of the N-C fragment, as well as other small, nonoverlapping CNBr-derived HEL peptides.
N-C-Induced T-Suppressor Cells in BIO Mice
The existence of limited regions on antigenic molecules able to activate suppressor T cells to nullify the positive effect induced by helper cells reactive with other epitopes has been demonstrated in the response to/3-galactosidase where a single CNBr peptide of/3-galactosidase-induced T-cell-mediated suppression specific for haptens coupled to the native enzyme (21) . Furthermore, a peptic fragment of bovine serum albumin has been demonstrated to induce suppressor T cells able to suppress the primary anti-BSA IgE response (22) . The regulatory role of limited portions on a protein antigen in affecting the overall response to the entire molecule has also been reported in the myelin basic protein system (23) . Myelin basic protein, which can induce experimental allergic encephalomyelitis, can be cleaved into distinct regions, one of which can cause the encephalitis; whereas a different one can specifically induce suppressor T cells to prevent the disease upon subsequent challenge with myelin basic protein. A similar interpretation has been given to the finding that a polypeptide of glutamic acid and alanine, which is immunogenic in H-2 s mice, can be converted into a nonimmunogenic antigen by the addition of 4-10% tyrosyl residues (24).
Although we have attributed the lack of response to HEL in B 10 mice to suppression induced by an epitope included in the N-C region, the B I0 lesion may be viewed from a different perspective. We know that the potential to produce Lii-specific help is not expressed in the nonresponder strain, presumably owing to N-C-induced suppressors. It is conceivable that N-C induction of help, demonstrable in the B10.A responder, may be the key deficit in the B10 mouse repertoire. If N-C-specific help is resistant, even to some extent, to T suppressor cells directed against the same N-C peptide, B 10.A could be a responder despite the existence of an adequate suppressive machinery (19, 20) .
H-2-1inked Ir gene control of the immune response is exerted at multiple levels of cell interaction events (1) (25) . The well-established role of macrophages in the intramolecular selection of critical antigenic determinants for presentation to T cells (26) and the results presented here are compatible with the hypothesis of a directive influence of macrophages not only in determinant selection but also in the MHC-controlled activation of different T-cell subpopulations by the same antigen fragment (27) .
Two major modes of cellular interaction, via antigen bridging (28) and idiotypic complementarity (29) , are currently utilized to explain cellular interactions in the immune response. Most of the results presented in this paper could be easily explaiiaed by antigen bridging (i.e., in B10 mice, N-C-specific receptors on suppressor T cells bind native HEL and then interact with Lii-specific helper cells across the HEL molecule). Recently, we have found common idiotypic determinants present on HELspecific suppressor T cells and on the large majority of anti-HEL antibodies produced in the secondary response, almost all with specificity for the N-C region (30) . Thus, the induction of idiotype-positive B-cell clones could be controlled by suppressor and helper T cells bearing idiotypically complementary receptors. The precise interaction between these two different regulatory pathways, which evidently coexist and determine the course of the immune response (31) (32) (33) , is currently under scrutiny in our laboratory.
In conclusion, the genetic nonresponsiveness of the B 10 strain to HEL seems to be a consequence of the predominant activation of suppressor T cells by a small fragment of this antigen. Furthermore, this same restricted region of the molecule is able to induce, in the congenic B 10.A responder partner of this strain, prevalent activation of helper-T-cell activity. Therefore, one of the levels of Ir gene control appears to be the ability to select specific antigenic determinants for the predominant activation of functionally different T-cell subpopulations.
SuiillTlary
We have examined the ability of two purified peptide fragments derived from hen (chicken) egg-white lysozyme (HEL); N-terminal, Co-terminal peptide (a.a. 1-17:cys 6-cys 127:120-129) and mixed disulfide Ln peptide (Lit) (a.a. 13-105) to induce antigen-specific suppression or help in B10 (H-2 b) nonresponder and B10.A (H-2 a) responder mice. An anti-HEL primary in vitro antibody response can be obtained in either strain by stimulation with HEL coupled to erythrocytes (RBC). Preimmunization with HEL-complete Freund's adjuvant-(CFA) or N-C-CFA-induced suppression of the anti-HEL PFC response to HEL-RBC in spleen cell cultures from B10 mice, whereas helper activity was demonstrated in cultures from B 10.A mice similarly immunized. LII-CFA priming elicited helper cells in both C57BL/10 Sn (B10) and B10.A/SgSn (B10.A) mice. The genetic nonresponsiveness of B 10 mice to HEL can therefore be attributed to the activation of suppressor T cells by a limited portion of the molecule (e.g., N-C) which prevent the potential response directed against other epitopes on the same molecule (e.g., Ln). One manifestation of major histocompatibility complex gene activity appears to be the intramolecular selection of different antigenic determinants leading to activation of functionally different T-cell subpopulations.
